Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion type Assertion NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_head.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion description "[Expression levels of the cell surface glycoprotein, CD7, and the serine protease, elastase 2 (ELA2), in the leukemic cells of patients with chronic myeloid leukemia (CML) have been associated with clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_provenance.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion evidence source_evidence_literature NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_provenance.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion SIO_000772 20175919 NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_provenance.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion wasDerivedFrom befree-2016 NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_provenance.
- NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_assertion wasGeneratedBy ECO_0000203 NP795256.RAL5Ag9I0J_xgJf2mv9hDnKMlQtLTHTXslpaTsarRqjoA130_provenance.